Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition

• Published in: Kidney international Vol. 64; no. 4; pp. 1462 - 1471
• Main Authors: Wei, Alice, Burns, Godfrey C., Williams, Brent A., Mohammed, Nazim B., Visintainer, Paul, Sivak, Steven L.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.10.2003; Nature Publishing; Elsevier Limited
• Subjects: Adult; AIDS-Associated Nephropathy - complications; AIDS-Associated Nephropathy - drug therapy; AIDS-Associated Nephropathy - physiopathology; angiotensin-converting enzyme inhibition; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Anti-Retroviral Agents - therapeutic use; Biological and medical sciences; Cohort Studies; Female; focal segmental glomerulosclerosis; Fosinopril - therapeutic use; HIV-associated nephropathy; Human immunodeficiency virus; Humans; Kidney Failure, Chronic - etiology; Kidneys; Male; Medical sciences; Middle Aged; Nephrology. Urinary tract diseases; nephrotic; proteinuria; Survival Analysis; Urinary system involvement in other diseases. Miscellaneous; HIV-associated nephropathy; nephrotic; angiotensin-converting enzyme inhibition; focal segmental glomerulosclerosis; proteinuria; Association; Cohort study; Complication; Kidney disease; Human; Immunopathology; Urinary system disease; Survivor; Retroviridae; AIDS; Terminal stage; Immune deficiency; Lentivirus; Long term; Infection; Virus; Chemotherapy; Nephropathy; Treatment; Viral disease; Risk factor; Renal failure; Human immunodeficiency virus; ACE inhibitor

Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Human immunodeficiency virus (HIV)–associated nephropathy (HIVAN) is the most common cause of end-stage renal disease (ESRD) in HIV-infected patients. Angiotensin-converting enzyme (ACE) inhibition...